Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05756868
Other study ID # AYildirim
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 13, 2021
Est. completion date June 20, 2022

Study information

Verified date February 2023
Source Eastern Mediterranean University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this randomized controlled trial is to to determine the effects of time-restricted feeding intervention on body weight, body composition, biochemical parameters and eating behaviors in overweight female individuals. The main questions it aims to answer are: 1. Does time-restricted feeding intervention reduce daily energy intake? 2. Does time-restricted dietary intervention result in body weight and body fat loss? 3. Does time-limited nutritional intervention lead to improvements in biochemical parameters? 4. Does time-restricted feeding intervention improve eating behavior and eating awareness? 5. Does time-restricted feeding intervention adversely affect diet quality? The participants in the intervention group will receive a time restricted feeding intervention (first meal at 10:00, last meal at 18:00) for 6 weeks. Meals of the participants are planned as 8 hours of eating and 16 hours of fasting. Participants in the control group will not receive any dietary intervention.


Description:

Following the ethics committee approval, the study will be carried out with the participants who applied to the Famagusta State Hospital Internal Medicine Polyclinic, Specialist Umut Hakligil. In order to start the study, TR Ministry of Health Nicosia Dr. Necessary permissions were obtained from the Ethics Committee of Burhan Nalbantoğlu State Hospital. The study is planned to be conducted with 40 female participants, who were not diagnosed with any disease by the physician, aged 19-65, slightly obese, with a BMI of 24.9-29.9 kg/m². Before being included in the research, participants will be informed about the purpose of the research and the applications to be made during the research. This information was supported with the valid consent form. Data Collection Tool: A questionnaire form developed in line with the research purpose was used as a data collection tool in the research. While collecting data on the individuals participating in the research, the "face-to-face interview method" (mask and distance due to the covid-19 pandemic) by taking necessary precautions such as rules of thumb) will be applied. Beginning of the Study: Participants who meet the study criteria and agree to participate in the study will be randomly assigned to the control group or intervention group. 1. Control group protocol; participants randomized to the control group will not receive any dietary intervention. In this process, how all participants should be asked before starting the study. If they are fed, they will be asked to continue in the same way and to maintain their physical activity level. 2. Intervention group protocol; participants randomized to the intervention group will receive a time-restricted feeding intervention for 6 weeks without energy restriction (adlibitum). Meals of the participants will be planned as 8 hours of eating and 16 hours of fasting. Meal timing will be set as follows: - First meal at 10:00, - Last meal at 18:00 in the evening Participants will be asked not to consume anything other than non-calorie drinks (water, only soda, unsweetened herbal teas, etc.) between 18:00 in the evening and 10:00 in the morning.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date June 20, 2022
Est. primary completion date October 24, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 19 Years to 65 Years
Eligibility Inclusion Criteria: 1. 19-65 age range 2. Female 3. BMI: 24.9-29.9 kg/m² 4. Maintaining general activity and exercise habits during the study period 5. Stable body weight (<4 kg weight loss or weight gain) for 6 months prior to the start of the study Exclusion Criteria: 1. Those with chronic disease (diabetes, hypertension, cardiovascular disease, etc.) 2. Drug users 3. Use of supplements that may affect blood lipid profile and blood sugar (omega-3 etc.) 4. Pregnant women 5. People in the lactation period 6. Menopause 7. Shift workers 8. Those who follow a Time Restricted (16:8) nutrition program before the study 9. Those who have followed any particular diet before the study 10. Those who frequently apply different weight loss diet programs

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Time restricted feeding
In the time-restricted nutrition intervention, the first meal is scheduled at 10:00 and the last meal at 18:00 (ad libitum). Eating for 8 hours and fasting for 16 hours are targeted.

Locations

Country Name City State
Cyprus Eastern Mediterranean University Famagusta

Sponsors (1)

Lead Sponsor Collaborator
Eastern Mediterranean University

Country where clinical trial is conducted

Cyprus, 

Outcome

Type Measure Description Time frame Safety issue
Primary Body Weight Body Weight 6 week
Primary Body Composition total body fluid 6 week
Primary Body Composition total fat mass 6 week
Primary Body Composition muscle mass 6 week
Primary Body Composition fat free mass 6 week
Primary Plasma lipids Total cholesterol 6 week
Primary Plasma lipids Hdl cholesterol 6 week
Primary Plasma lipids Ldl cholesterol 6 week
Primary Plasma lipids Triglyceride 6 week
Primary Blood Pressure Systolic blood pressure 6 week
Primary Blood Pressure Diastolic blood pressure 6 week
Primary Pulse 6 week
Primary Biochemistry blood glucose 6 week
Primary Biochemistry fasting insulin 6 week
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03754920 - Prolonged Fasting With Meditation and Mild Physical Exercise N/A
Completed NCT05272332 - Gastric Ultrasound Prior to Extubation
Completed NCT04247464 - Short-term Fasting as an Enhancer of Chemotherapy: Pilot Clinical Study on Colorectal Carcinoma Patients N/A
Completed NCT01067001 - Minocycline HCl Extended Release Tablets 135 mg Oral Bioequivalence Study N/A
Completed NCT00757094 - Safety and Feasibility of Fasting While Receiving Chemotherapy N/A
Completed NCT01506713 - Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions Phase 1
Completed NCT04514380 - Effect of Drinking Carbohydrate-containing Fluids on Gastric Residual Volume in Elderly Patients
Completed NCT05134207 - The Effect of Oral Carbohydrate Solution on Anxiety and Comfort in Patients Undergoing Hip Arthroplasty N/A
Completed NCT05031598 - Long-term Fasting: Multi-system Adaptations in Humans N/A
Recruiting NCT04501393 - Recommended Clear Fluid Intake Volume at 2 Hours Prior to Esophagogastroduodenoscopy for Adult Patients N/A
Enrolling by invitation NCT04027478 - Can Fasting Decrease the Side Effects of Chemotherapy? N/A
Completed NCT05219136 - Improve the Comfort, Safety and Quality of Upper Endoscopy by a Modified Fasting Protocol N/A
Recruiting NCT04625608 - Effect of Premedicant Oral Paracetamol on Gastric Volume and pH Phase 4
Not yet recruiting NCT02562638 - Pre-Procedural Fasting in Cardiac Intervention N/A
Completed NCT01949987 - Does Oral Intake Decreases Postoperative Pain Score in Children N/A
Completed NCT01954836 - Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial N/A
Completed NCT01746719 - Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting Condition Phase 1
Completed NCT01721187 - Satiety Effects on the Neural Valuation of Food N/A
Completed NCT01713647 - Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions Phase 1
Completed NCT01831700 - Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions Phase 1